Do we know all about acetylcysteine?
- 作者: Klyachkina I.L.1
-
隶属关系:
- Russian Medical Academy of Continuous Professional Education
- 期: 卷 28, 编号 10 (2021)
- 页面: 103-110
- 栏目: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/313263
- DOI: https://doi.org/10.18565/pharmateca.2021.10.W3-1W
- ID: 313263
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
Symptomatic therapY., including antipyretics, plays center stage in the treatment of the new coronavirus infection COVID-19. The safest drug is paracetamol, which is included in outpatient treatment regimens for a new coronavirus infection (COVID-19). Paracetamol is considered a well-tolerated drug, however, despite this facT., there is a steady increase in the number of reported cases of paracetamol-induced hepatic intoxication worldwide every year. N-acetylcysteine (NAC) is approved by FDA and therefore recognized by the WHO as an essential drug widely used in the treatment of paracetamol (acetaminophen) overdose.
全文:
作者简介
Irina Klyachkina
Russian Medical Academy of Continuous Professional Education
Email: formozailk2012@yandex.ru
Cand. Sci. (Med.), Associate Professor at the Department of Pulmonology Moscow, Russia
参考
- Rushworth G.F., Megson I.L. Existing and potential therapeutic uses for N-acetylcysteine. The need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther 2014;141:150-59. doi: 10.1016/j.pharmthera.2013.09.006.
- Sheffner A.L., et al. the in vitro reduction in viscosity of human tracheobronchial secretions by acetylcysteine. Am Rev Resp Dis. 1964;90:721-29. doi: 10.1164/arrd.1964.90.5.721.
- Aruoma O.I., Halliwell B., Hoey B.M., Butler J. The antioxidant action of N-acetylcysteine:its reaction with hydrogen peroxide and hypochlorous acid. Free Radic Biol Med. 1989; 6(6):593-7.
- AldiniG.,AltomareA.,BaronG.,etal.N-Acetylcysteine as an antioxidant and disulphide breaking agent: The reasons why. Free Radic Res. 2018;52:751-62. doi: 10.1080/10715762.2018.1468564.
- Tenorio M.C. dos S., Graciliano N.G., Moura F.A., at al. N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants (Basel). 2021;10(6):967. Published on-line 2021 Jun 16. Doi: 10.3390/ antiox10060967.
- Samuni Y., Goldstein S., Dean O.M., Berk M. The chemistryandbiologicalactivitiesofN-acetylcysteine. Biochim Biophys Acta. 2013;1830:4117-29. doi: 10.1080/10715762.2018.1468564.
- Atefi N., Behrangi E., Mozafarpoor S., et al. N-acetylcysteine and coronavirus disease 2019. May it work as a beneficial preventive and adjuvant therapy? A comprehensive review studies. J Res Med Sci. 2020;25:109. Published on-line 2020 Nov 26. doi: 10.4103/jrms.JRMS_777_20.
- Временные методические рекомендации: профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 11 (07.05.2021)
- Sestili P., Fimognari C. Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? Front Pharmacol. 2020;11:579944. Published on-line 2020 Oct 7. doi: 10.3389/fphar. 2020.579944
- Временные методические рекомендации: лекарственная терапия острых респираторных вирусных инфекций (ОРВИ) в амбулаторной практике в период эпидемии COVID-19 (версия 2 от 16.04.2020)
- Розенсон О.Л. Вопросы безопасности парацетамола и парацетамол-содержащих препаратов. РМЖ. 1999;20:68- 73
- Jozwiak-Bebenista M., Nowak J.Z. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm. 2014;71(1):11-23.
- Lee W.M. Acute liver failure. Semin Respir Crit Care Med. 2012;33:36-45. doi: 10.1055/s-0032-1301733.
- Yoon E., Babar A., Choudhary M., et al. Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update. J Clin Transllat Hepatol. 2016;4(2):131-42. Doi: 10.14218/ JCTH.2015.00052.
- Lieber C.S. Medical disorders of alcoholism. N Engl J Med. 1995;333:1058-65. Doi: 10.1056/
- Perneger T.V., Whelton P.K., Klag M.J. Risk of kidney failure associated with the use of acetominophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med. 1994;331:1675-712. Doi:10.1056/ NEJM199412223312502.
- Larson A.M., Polson J., Fontana R.J., et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatol. Wiley-Liss, 2005;42(6):1364-72. doi: 10.1002/hep.20948.
- De Andrade K.Q., Moura F.A., Dos Santos J.M., et al. Oxidative stress and inflammation in hepatic diseases: Therapeutic possibilities of N-Acetylcysteine. Int J Mol Sci. 2015; 16:30269-308. doi: 10.3390/ijms 161226225.
- Chiew A.L., Reith D., Pomerleau A., et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2020;212:175-83. doi: 10.5694/mja2.50428.
- Jaeschke H. Acetaminophen - Dose-dependent Drug Hepatotoxicity and Acute Liver Failure in Patients. Dig Dis. 2015;33(4):464-71. Published onl-ine 2015 Jul 6. doi: 10.1159/000374090.
- De Flora S., Grassi C., Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with longterm N-acetylcysteine treatment. Eur Respir J. 1997;10:1535-41. doi: 10.1183/09031936.97. 10071535.
补充文件
